Moore Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
130,195
-180,929
-58% -$1.11M 0.02% 451
2026
Q1
$2.38M Buy
+311,124
New +$2.38M 0.05% 260

Other funds holding REPL

Moore Capital Management's REPL Position: Q2 2026 in Review

Moore Capital Management reduced its Replimune Group (REPL) stake by 58% in Q2 2026, selling an estimated $1.11M and leaving 130,195 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #451.

Moore Capital Management first reported a position in REPL in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.38M in Q1 2026. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Moore Capital Management held 130,195 shares of Replimune Group worth $1.44M as of Q2 2026.
  • Moore Capital Management sold 180,929 Replimune Group shares in Q2 2026, an estimated $1.11M.
  • Replimune Group made up 0.02% of Moore Capital Management's portfolio in Q2 2026, its #451 holding.
  • Moore Capital Management first reported a position in Replimune Group in Q1 2026 and has held it in 2 quarters since.
  • Moore Capital Management's Replimune Group position peaked at $2.38M in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.